Skip to content

Hemochromatosis Type 3 C1858664

Published: July 22, 2026Updated: August 20, 2026

Hemochromatosis Type 3 is a hereditary iron overload disorder caused by gene mutations affecting iron regulation. It can damage the liver, heart, and other organs. Treatment involves phlebotomy to lower iron levels.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Fatigue or weight changes

(metabolic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Fatigue

(metabolic)

Arthralgia

(metabolic)

Diabetes mellitus

(metabolic)

Liver cirrhosis

(metabolic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Exercise prescription and weight management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Phlebotomy-based iron depletion

Therapeutic phlebotomy remains a cornerstone of treatment, though patients with TFR2-related hemochromatosis may require earlier or more intensive intervention compared to HFE-related disease.

surgical
3

Iron chelation therapy

Chelation therapy becomes particularly important when phlebotomy is insufficient or contraindicated, providing an alternative pathway for iron elimination in type 3 disease.

medication

Additional treatment options

Hepatic evaluation program

Detailed liver assessment including elastography, biopsy when indicated, and serial monitoring for cirrhosis development and hepatocellular carcinoma risk.

monitoring

Cardiac iron assessment

Cardiac MRI with T2* imaging to detect and quantify myocardial iron deposition, with echocardiography and ECG surveillance for cardiomyopathy development.

monitoring

Targeted nutritional counseling

Individualized dietary planning to minimize iron absorption including avoidance of red meat, shellfish, iron-fortified products, and vitamin C supplementation with meals.

dietary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Hemochromatosis Type 3 C1858664?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Bacon BR, Adams PC, Kowdley KV, Powell LW, Tavill AS. Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology. 2011.

guideline2011
2

Pietrangelo A. Hereditary hemochromatosis: new insights in pathogenesis and diagnosis. Arch Med Res. 2020.

review2020
3

Camaschella C, Roetto A, Calì A, et al. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet. 2000.

clinical_trial2000
4

Ekanayake D, Rodd C, Miller C, Hershberger M, Cuellar N. Systematic review of genotype-phenotype correlations in hereditary hemochromatosis types 2, 3, and 4. Blood Rev. 2022.

meta_analysis2022

Medication Comparisons

Compare medications used to treat Hemochromatosis Type 3 C1858664. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy